An efficient method for the synthesis of peptide aldehyde libraries employed in the discovery of reversible SARS coronavirus main protease (SARS-CoV Mpro) inhibitors

被引:51
作者
Al-Gharabli, Samer I.
Shah, Syed T. Ali
Weik, Steffen
Schmidt, Marco F.
Mesters, Jeroen R.
Kuhn, Daniel
Klebe, Gerhard
Hilgenfeld, Rolf
Rademann, Joerg
机构
[1] Univ Lubeck, Inst Biochem, Ctr Struct & Cell Biol Med, D-23538 Lubeck, Germany
[2] Univ Marburg, Inst Pharmazeut Chem, D-35032 Marburg, Germany
[3] Free Univ Berlin, Inst Chem & Biochem, D-14195 Berlin, Germany
[4] Leibniz Inst Mol Pharmacol, Dept Med Chem, D-13125 Berlin, Germany
关键词
aldehydes; cysteine proteases; inhibitors; SARS; solid-phase synthesis; viruses;
D O I
10.1002/cbic.200500533
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
A method for the parallel solid-phase synthesis of peptide aldehydes has been developed. Protected amino acid aldehydes obtained by the racemization-free oxidation of amino alcohols with Dess-Martin periodinane were immobilized on threonyl resins as oxazolidines. Following Boc protection of the ring nitrogen to yield the N-protected oxazolidine linker, peptide synthesis was performed efficiently on this resin. A peptide aldehyde library was designed for targeting the SARS coronavirus main protease, SARS-CoV M-pro (also known as 3CL(pro)), on the basis of three different reported binding modes and supported by virtual screening. A set of 25 peptide aldehydes was prepared by this method and investigated in inhibitions assays against SARS-CoV M-pro. Several potent inhibitors were found with IC50 values in the low micromolar range. An IC50 of 7.5 mu M was found for AcNSTSQ-H and AcESTLQ-H. Interestingly, the most potent inhibitors seem to bind to SARS-CoV M-pro in a noncanonical binding mode.
引用
收藏
页码:1048 / 1055
页数:8
相关论文
共 41 条
[1]   ASYMMETRIC-SYNTHESIS OF HOMOCHIRAL 1,2-DIOLS VIA N-BOC OXAZOLIDINES [J].
AGAMI, C ;
COUTY, F ;
LEQUESNE, C .
TETRAHEDRON LETTERS, 1994, 35 (20) :3309-3312
[2]   Coronavirus main proteinase (3CLpro) structure:: Basis for design of anti-SARS drugs [J].
Anand, K ;
Ziebuhr, J ;
Wadhwani, P ;
Mesters, JR ;
Hilgenfeld, R .
SCIENCE, 2003, 300 (5626) :1763-1767
[3]  
Anand K, 2005, BIRK ADV INFECT DIS, P173
[4]   SCREENING FOR FIBRINOLYSIS INHIBITORY EFFECT OF SYNTHETIC THROMBIN INHIBITORS [J].
BARABAS, E ;
SZELL, E ;
BAJUSZ, S .
BLOOD COAGULATION & FIBRINOLYSIS, 1993, 4 (02) :243-248
[5]  
Baumeister EG, 2005, MEDICINA-BUENOS AIRE, V65, P36
[6]   Solid-phase synthesis of oligourea peptidomimetics employing the Fmoc protection strategy [J].
Boeijen, A ;
van Ameijde, J ;
Liskamp, RMJ .
JOURNAL OF ORGANIC CHEMISTRY, 2001, 66 (25) :8454-8462
[7]   Coronavirus genome structure and replication [J].
Brian, DA ;
Baric, RS .
CORONAVIRUS REPLICATION AND REVERSE GENETICS, 2005, 287 :1-30
[8]   PREPARATIONS OF PSI-PEPTIDE BOND AND PEPTIDE-ALDEHYDE INHIBITORS OF ATRIAL GRANULE SERINE PROTEINASE, A CANDIDATE PROCESSING ENZYME OF PROATRIAL NATRIURETIC FACTOR [J].
DAMODARAN, A ;
HARRIS, RB .
JOURNAL OF PROTEIN CHEMISTRY, 1995, 14 (06) :431-440
[9]   Conservation medicine and a new agenda for emerging diseases [J].
Daszak, P ;
Tabor, GM ;
Kilpatrick, AM ;
Epstein, J ;
Plowright, R .
IMPACT OF ECOLOGICAL CHANGES ON TROPICAL ANIMAL HEALTH AND DISEASE CONTROL, 2004, 1026 :1-11
[10]   A simple linker for the attachment of aldehydes to the solid phase. Application to solid phase synthesis by the Multipin(TM) method. [J].
Ede, NJ ;
Bray, AM .
TETRAHEDRON LETTERS, 1997, 38 (40) :7119-7122